Europe: Shares inch higher; AstraZeneca tumbles on halting vaccine trials

Published Wed, Sep 9, 2020 · 07:24 AM

    DeeperDive is a beta AI feature. Refer to full articles for the facts.

    [BENGALURU] European shares steadied on Wednesday after hefty declines in the previous session, although sentiment was rattled by AstraZeneca suspending global trials for its Covid-19 vaccine.

    AstraZeneca shares slipped 1.3 per cent as it also paused large late-stage trials of its experimental vaccine due to an unexplained illness in a study participant.

    The pan-European Stoxx 600 index edged 0.1 per cent higher at 7.10am GMT, with travel and leisure stocks among the biggest decliners in early trading.

    REUTERS

    Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

    Share with us your feedback on BT's products and services